Results 151 to 160 of about 13,248 (184)
Combination Therapy with Ceftazidime-Avibactam, Aztreonam, and Topical Polymyxin B for NDM-Producing <i>Klebsiella pneumoniae</i> CNS Infection: A Case Report. [PDF]
Infect Drug ResistQi G +6 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-avibactam and comparators against <i>Enterobacterales</i> isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022. [PDF]
Microbiol SpectrRossolini GM +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Avibactam Pharmacokinetic/Pharmacodynamic Targets [PDF]
Antimicrobial Agents and Chemotherapy, 2018 Avibactam is a novel non--lactam -lactamase inhibitor that has been approved in the United States and Europe for use in combination with ceftazidime.
Shampa Das +2 more
exaly +2 more sources
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies [PDF]
Diagnostic Microbiology and Infectious DiseaseWe described the emergence of ceftazidime/avibactam and cefiderocol cross-resistance in patients with KPC-producing Klebsiella pneumoniae infections. All strains with ceftazidime/avibactam and cefiderocol cross-resistance showed point mutations on KPC Ω ...
Maddalena Giannella +2 more
exaly +3 more sources